215 related articles for article (PubMed ID: 15624028)
1. No effect of short term ranitidine intake on diclofenac pharmacokinetics.
Leucuţa A; Vlase L; Farcau D; Nanulescu M
Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction study between ranitidine and metoclopramide.
Leucuţa A; Vlase L; Farcău D; Nanulescu M
Rom J Gastroenterol; 2004 Sep; 13(3):211-4. PubMed ID: 15470533
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
5. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine.
Leucuta A; Vlase L; Farcau D; Nanulescu M
Drug Metabol Drug Interact; 2004; 20(4):273-81. PubMed ID: 15663296
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bioavailability and pharmacokinetics of diclofenac sodium and diclofenac potassium in normal and dehydrated rabbits.
Ahmad M; Iqbal M; Murtaza G
Yao Xue Xue Bao; 2009 Jan; 44(1):80-4. PubMed ID: 19350827
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers.
Vlase L; Leucuta A; Farcau D; Nanulescu M
Biopharm Drug Dispos; 2006 Sep; 27(6):285-9. PubMed ID: 16770757
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of diclofenac sodium in normal man.
Hasan SM; Ahmed T; Talib N; Hasan F
Pak J Pharm Sci; 2005 Jan; 18(1):18-24. PubMed ID: 16431378
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Lissy M; Stiff DD; Kowalski MM; Moore KA
Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
[TBL] [Abstract][Full Text] [Related]
12. The effect of antacid and ranitidine on droxicam pharmacokinetics.
Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
[TBL] [Abstract][Full Text] [Related]
13. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
[TBL] [Abstract][Full Text] [Related]
14. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy.
Kowalski M; Stoker DG; Bon C; Moore KA; Boesing SE
Am J Ther; 2010; 17(5):460-8. PubMed ID: 19531931
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of a formulation containing a diclofenac-ranitidine combination.
Carrasco-Portugal Mdel C; Aguilar-Cota ME; Pérez-Urizar J; Cabrera O; Herrera JE; Flores-Murrieta FJ
Proc West Pharmacol Soc; 2002; 45():8-10. PubMed ID: 12434510
[No Abstract] [Full Text] [Related]
17. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
Ramakrishna S; Fadnavis NW; Diwan PV
Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms.
Dammann HG; Simon-Schultz J; Steinhoff I; Damaschke A; Schmoldt A; Sallowsky E
Br J Clin Pharmacol; 1993 Oct; 36(4):345-9. PubMed ID: 12959313
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans.
Mascher H
Drug Des Deliv; 1989 Jun; 4(4):303-11. PubMed ID: 2775450
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
